QUINLAN PAUL T (General Counsel and Secretary) sold 23.1% of their position (9K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $706.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9K
Price / share
$7.80
Trade value
$70.20K
% of position
Common Stock
Shares
−400.00
Price / share
$74.90
Trade value
$29.96K
% of position
Common Stock
Shares
−500.00
Price / share
$76.12
Trade value
$38.06K
% of position
Common Stock
Shares
−1K
Price / share
$77.20
Trade value
$77.20K
% of position
Common Stock
Shares
−4.10K
Price / share
$78.79
Trade value
$323.04K
% of position
Common Stock
Shares
−3K
Price / share
$79.49
Trade value
$238.47K
% of position
Net shares
+0.00
Net value
-$636.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/20/2026 | M · Option Exercise | +9K | $7.80 | $70.20K | 30.0% | 30K | 38.99K |
| Common Stock Direct | 10/20/2026 | S · Sale | −400.00 | $74.90 | $29.96K | 1.0% | 38.99K | 38.59K |
| Common Stock Direct | 10/20/2026 | S · Sale | −500.00 | $76.12 | $38.06K | 1.3% | 38.59K | 38.09K |
| Common Stock Direct | 10/20/2026 | S · Sale | −1K | $77.20 | $77.20K | 2.6% | 38.09K | 37.09K |
| Common Stock Direct | 10/20/2026 | S · Sale | −4.10K | $78.79 | $323.04K | 11.1% | 37.09K | 32.99K |
| Common Stock Direct | 10/20/2026 | S · Sale | −3K | $79.49 | $238.47K | 9.1% | 32.99K | 30K |
| Total | +0.00 | -$636.53K | ||||||
Employee Warrant (right to buy)
Common Stock
9K shares
Shares
−9K
Strike price
7.8
Held after
71K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock9K shares | 10/20/2026 | M · Option Exercise | −9K | 7.8 | — | 71K |